Platelet counts, cholesterol levels, liver fibrosis markers and transient elastography measurements in predicting severe liver fibrosis or liver cirrhosis as determined by magnetic resonance imaging
| . | C statistic . | 95% CI . | P-value . |
|---|---|---|---|
| Current study: YACHT score | 0.817 ± 0.071 | (0.679, 0.955) | <0.001 |
| Forn’s index | 0.725 ± 0.080 | (0.569, 0.882) | 0.013 |
| FibroScan (kPa) | 0.676 ± 0.084 | (0.512, 0.841) | 0.051 |
| Fontan hepatic index | 0.662 ± 0.084 | (0.498, 0.827) | 0.073 |
| APRI | 0.606 ± 0.090 | (0.430, 0.781) | 0.242 |
| Fibrosis-4 score | 0.601 ± 0.087 | (0.431, 0.772) | 0.262 |
| Cholesterol | 0.339 ± 0.086 | (0.170, 0.508) | 0.074 |
| Platelet count | 0.293 ± 0.083 | (0.130, 0.456) | 0.022 |
| . | C statistic . | 95% CI . | P-value . |
|---|---|---|---|
| Current study: YACHT score | 0.817 ± 0.071 | (0.679, 0.955) | <0.001 |
| Forn’s index | 0.725 ± 0.080 | (0.569, 0.882) | 0.013 |
| FibroScan (kPa) | 0.676 ± 0.084 | (0.512, 0.841) | 0.051 |
| Fontan hepatic index | 0.662 ± 0.084 | (0.498, 0.827) | 0.073 |
| APRI | 0.606 ± 0.090 | (0.430, 0.781) | 0.242 |
| Fibrosis-4 score | 0.601 ± 0.087 | (0.431, 0.772) | 0.262 |
| Cholesterol | 0.339 ± 0.086 | (0.170, 0.508) | 0.074 |
| Platelet count | 0.293 ± 0.083 | (0.130, 0.456) | 0.022 |
Mean±SD. The bold values indicate the variables with a P-value < 0.05.
YACHT (Years after Fontan, plAtelet count, CHolesterol, Transient elastography) score = 12.8 + 0.9 × (years after Fontan) – 0.07 × platelet count (103/ul) – 0.2 × cholesterol (mg/dl) + 1.14 × FibroScan (kPa).
APRI: AST-to-platelet ratio index.
Platelet counts, cholesterol levels, liver fibrosis markers and transient elastography measurements in predicting severe liver fibrosis or liver cirrhosis as determined by magnetic resonance imaging
| . | C statistic . | 95% CI . | P-value . |
|---|---|---|---|
| Current study: YACHT score | 0.817 ± 0.071 | (0.679, 0.955) | <0.001 |
| Forn’s index | 0.725 ± 0.080 | (0.569, 0.882) | 0.013 |
| FibroScan (kPa) | 0.676 ± 0.084 | (0.512, 0.841) | 0.051 |
| Fontan hepatic index | 0.662 ± 0.084 | (0.498, 0.827) | 0.073 |
| APRI | 0.606 ± 0.090 | (0.430, 0.781) | 0.242 |
| Fibrosis-4 score | 0.601 ± 0.087 | (0.431, 0.772) | 0.262 |
| Cholesterol | 0.339 ± 0.086 | (0.170, 0.508) | 0.074 |
| Platelet count | 0.293 ± 0.083 | (0.130, 0.456) | 0.022 |
| . | C statistic . | 95% CI . | P-value . |
|---|---|---|---|
| Current study: YACHT score | 0.817 ± 0.071 | (0.679, 0.955) | <0.001 |
| Forn’s index | 0.725 ± 0.080 | (0.569, 0.882) | 0.013 |
| FibroScan (kPa) | 0.676 ± 0.084 | (0.512, 0.841) | 0.051 |
| Fontan hepatic index | 0.662 ± 0.084 | (0.498, 0.827) | 0.073 |
| APRI | 0.606 ± 0.090 | (0.430, 0.781) | 0.242 |
| Fibrosis-4 score | 0.601 ± 0.087 | (0.431, 0.772) | 0.262 |
| Cholesterol | 0.339 ± 0.086 | (0.170, 0.508) | 0.074 |
| Platelet count | 0.293 ± 0.083 | (0.130, 0.456) | 0.022 |
Mean±SD. The bold values indicate the variables with a P-value < 0.05.
YACHT (Years after Fontan, plAtelet count, CHolesterol, Transient elastography) score = 12.8 + 0.9 × (years after Fontan) – 0.07 × platelet count (103/ul) – 0.2 × cholesterol (mg/dl) + 1.14 × FibroScan (kPa).
APRI: AST-to-platelet ratio index.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
